Vanguard Capital Management
DGX icon

Vanguard Capital Management’s Quest Diagnostics DGX Stock Holding History

Vanguard Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53B Buy
7,233,394
+87,722
+1% +$17.2M 0.03% 396
2026
Q1 		$1.4B Buy
+7,145,672
New +$1.39B 0.03% 392

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management's DGX Position: Q2 2026 in Review

Vanguard Capital Management increased its Quest Diagnostics (DGX) stake by 1.2% in Q2 2026, buying an estimated $17.2M and bringing the position to 7,233,394 shares worth $1.53B. The position accounts for 0.03% of the portfolio, ranked #396.

Vanguard Capital Management first reported a position in DGX in Q1 2026 and has held it in 2 quarters since. 1,046 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Vanguard Capital Management held 7,233,394 shares of Quest Diagnostics worth $1.53B as of Q2 2026.
  • Vanguard Capital Management bought 87,722 Quest Diagnostics shares in Q2 2026, an estimated $17.2M.
  • Quest Diagnostics made up 0.03% of Vanguard Capital Management's portfolio in Q2 2026, its #396 holding.
  • Vanguard Capital Management first reported a position in Quest Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.